ALLO $0.00 ( 0.00%) Quote details

Establish your trading edge with a set of smart tools for serious trades. Upgrade Account
stock

Allogene Therapeutics Inc

NASDAQ | ALLO

1.57

USD

0.00 ( 0.00%)

AT CLOSE (AS OF Apr 24, 2025)

$350M

MARKET CAP

-

P/E Ratio

-1.32

EPS

$3.8

52 Week High

$1.2

52 Week Low

LIFE SCIENCES

Sector

ALLO Chart

1D
Area

Trade Smarter

Take control of your trading journey with a set of smart tools for serious trades

Icon For Time-schedule

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Icon For Search

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Icon For Clipboard-list

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

ALLO Technicals

Tags:

ALLO Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $22K
Total Revenue $22K
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$273M
Selling General And Administrative $65M
Research And Development $192M
Operating Expenses $273M
Investment Income Net -
Net Interest Income $20M
Interest Income $20M
Interest Expense $181K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $14M
Income Before Tax -$257M
Income Tax Expense $443K
Interest And Debt Expense -
Net Income From Continuing Operations -$258M
Comprehensive Income Net Of Tax -
Ebit -$257M
Ebitda -$243M
Net Income -$258M

Revenue & Profitability

Earnings Performance

ALLO Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $549M
Total Current Assets $303M
Cash And Cash Equivalents At Carrying Value $75M
Cash And Short Term Investments $75M
Inventory -
Current Net Receivables -
Total Non Current Assets $245M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $81M
Short Term Investments $217M
Other Current Assets $11M
Other Non Current Assets -
Total Liabilities $127M
Total Current Liabilities $36M
Current Accounts Payable -
Deferred Revenue -
Current Debt -
Short Term Debt -
Total Non Current Liabilities $91M
Capital Lease Obligations $91M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $83M
Other Current Liabilities $30M
Other Non Current Liabilities $7.8M
Total Shareholder Equity $422M
Treasury Stock -
Retained Earnings -$1.8B
Common Stock $212K
Common Stock Shares Outstanding $195M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$200M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $14M
Capital Expenditures $694K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $117M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $1.5M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$258M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $22K
Total Revenue $22K
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$273M
Selling General And Administrative $65M
Research And Development $192M
Operating Expenses $273M
Investment Income Net -
Net Interest Income $20M
Interest Income $20M
Interest Expense $181K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $14M
Income Before Tax -$257M
Income Tax Expense $443K
Interest And Debt Expense -
Net Income From Continuing Operations -$258M
Comprehensive Income Net Of Tax -
Ebit -$257M
Ebitda -$243M
Net Income -$258M

ALLO News

ALLO Profile

Allogene Therapeutics Inc Profile

Sector: LIFE SCIENCES

Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Allogene Therapeutics, Inc., a clinical-stage immuno-oncology company, develops and markets genetically engineered allogeneic T-cell therapies for the treatment of cancer. The company is headquartered in South San Francisco, California.

DMN
-12.20%
$0.0036
GNLN
-93.89%
$0.015
OMEX
100.07%
$0.8521
NVDA
3.62%
$106.43
LRHC
25.39%
$0.1531
STSS
-26.71%
$0.0214
CNEY
9.44%
$0.1391
PET
38.26%
$0.1525
INTC
4.37%
$21.49
PLTR
7.27%
$100.82
TSLA
3.50%
$259.51
ALTM
0.00%
$5.84
F
2.86%
$10.06
AREB
27.69%
$3.92
CERO
38.85%
$1.11
NOK
-8.47%
$4.86
AAL
3.11%
$9.61
TMC
44.71%
$3.69
OCEA
-52.20%
$0.0098
SOFI
4.86%
$12.31
LCID
2.51%
$2.45
BTG
-0.32%
$3.15
NIO
6.36%
$4.18
LYT
-16.78%
$0.0982
PLUG
0.94%
$0.8486
CEP
50.30%
$24.8
SMCI
8.85%
$35.81
ZENA
18.72%
$2.6
ABEV
0.41%
$2.46
AAPL
1.84%
$208.37
AMZN
3.29%
$186.54
LGMK
1.09%
$0.0093
HOOD
7.81%
$48.15
TAL
-18.67%
$8.93
T
1.25%
$27.53
WULF
8.96%
$3.04
DNN
4.04%
$1.415
GOOGL
2.53%
$159.28
TLRY
11.81%
$0.4923
APLD
11.27%
$4.54
ERIC
-0.96%
$8.23
PFE
1.74%
$22.78
RIG
5.53%
$2.29
SNAP
4.39%
$8.33
AMD
4.51%
$94.47
SOUN
7.20%
$9.38
PBR
-0.83%
$11.375
BAC
2.26%
$39.625
NGD
0.87%
$3.46
AGMH
-32.76%
$0.039
ITUB
2.68%
$6.14
IQ
2.14%
$1.91
GOOG
2.38%
$161.47
GRAB
6.85%
$4.68
VALE
2.09%
$9.75
HTZ
2.06%
$8.65
AMCR
1.47%
$9.66
ME
-21.26%
$0.6063
CUTR
-10.19%
$0.0969
WBD
2.04%
$8.5
CMG
1.60%
$49.54
BBD
1.93%
$2.375
MARA
-0.85%
$14.01
QBTS
3.09%
$7.35
AZUL
-27.10%
$1.13
AVGO
6.35%
$188.15
RGTI
2.09%
$9.3
BON
5.30%
$0.0616
BTE
0.00%
$1.64
AGNC
1.45%
$8.735
VRN
2.69%
$6.11
JD
-3.25%
$32.47
TWG
-4.32%
$0.1441
RIOT
3.87%
$7.79
VHAI
7.69%
$0.0014
MU
6.16%
$77.42
FCX
6.93%
$37.63
CLSK
-0.11%
$8.86
ACHR
6.21%
$8.55
UBER
5.87%
$78.1
MSFT
3.45%
$387.3
LUV
3.68%
$26.46
CSCO
1.19%
$56.29
PONY
39.41%
$7.57
BMY
0.33%
$48.69
PG
-3.74%
$159.53
JYD
-15.22%
$0.225
PTEN
3.74%
$6.1
RIVN
2.46%
$12.09
MRVL
6.62%
$57.33
LYG
0.00%
$3.91
FNA
0.00%
$13.09
XP
3.32%
$15.56
TXN
6.56%
$162.13
HPE
5.50%
$16.195
LGCB
4.79%
$1.97
TSM
4.04%
$164.18
JBLU
1.55%
$3.94
KGC
2.23%
$14.67
FFAI
27.01%
$1.14
DMN
-12.20%
$0.0036
GNLN
-93.89%
$0.015
OMEX
100.07%
$0.8521
NVDA
3.62%
$106.43
LRHC
25.39%
$0.1531
STSS
-26.71%
$0.0214
CNEY
9.44%
$0.1391
PET
38.26%
$0.1525
INTC
4.37%
$21.49
PLTR
7.27%
$100.82
TSLA
3.50%
$259.51
ALTM
0.00%
$5.84
F
2.86%
$10.06
AREB
27.69%
$3.92
CERO
38.85%
$1.11
NOK
-8.47%
$4.86
AAL
3.11%
$9.61
TMC
44.71%
$3.69
OCEA
-52.20%
$0.0098
SOFI
4.86%
$12.31
LCID
2.51%
$2.45
BTG
-0.32%
$3.15
NIO
6.36%
$4.18
LYT
-16.78%
$0.0982
PLUG
0.94%
$0.8486
CEP
50.30%
$24.8
SMCI
8.85%
$35.81
ZENA
18.72%
$2.6
ABEV
0.41%
$2.46
AAPL
1.84%
$208.37
AMZN
3.29%
$186.54
LGMK
1.09%
$0.0093
HOOD
7.81%
$48.15
TAL
-18.67%
$8.93
T
1.25%
$27.53
WULF
8.96%
$3.04
DNN
4.04%
$1.415
GOOGL
2.53%
$159.28
TLRY
11.81%
$0.4923
APLD
11.27%
$4.54
ERIC
-0.96%
$8.23
PFE
1.74%
$22.78
RIG
5.53%
$2.29
SNAP
4.39%
$8.33
AMD
4.51%
$94.47
SOUN
7.20%
$9.38
PBR
-0.83%
$11.375
BAC
2.26%
$39.625
NGD
0.87%
$3.46
AGMH
-32.76%
$0.039
ITUB
2.68%
$6.14
IQ
2.14%
$1.91
GOOG
2.38%
$161.47
GRAB
6.85%
$4.68
VALE
2.09%
$9.75
HTZ
2.06%
$8.65
AMCR
1.47%
$9.66
ME
-21.26%
$0.6063
CUTR
-10.19%
$0.0969
WBD
2.04%
$8.5
CMG
1.60%
$49.54
BBD
1.93%
$2.375
MARA
-0.85%
$14.01
QBTS
3.09%
$7.35
AZUL
-27.10%
$1.13
AVGO
6.35%
$188.15
RGTI
2.09%
$9.3
BON
5.30%
$0.0616
BTE
0.00%
$1.64
AGNC
1.45%
$8.735
VRN
2.69%
$6.11
JD
-3.25%
$32.47
TWG
-4.32%
$0.1441
RIOT
3.87%
$7.79
VHAI
7.69%
$0.0014
MU
6.16%
$77.42
FCX
6.93%
$37.63
CLSK
-0.11%
$8.86
ACHR
6.21%
$8.55
UBER
5.87%
$78.1
MSFT
3.45%
$387.3
LUV
3.68%
$26.46
CSCO
1.19%
$56.29
PONY
39.41%
$7.57
BMY
0.33%
$48.69
PG
-3.74%
$159.53
JYD
-15.22%
$0.225
PTEN
3.74%
$6.1
RIVN
2.46%
$12.09
MRVL
6.62%
$57.33
LYG
0.00%
$3.91
FNA
0.00%
$13.09
XP
3.32%
$15.56
TXN
6.56%
$162.13
HPE
5.50%
$16.195
LGCB
4.79%
$1.97
TSM
4.04%
$164.18
JBLU
1.55%
$3.94
KGC
2.23%
$14.67
FFAI
27.01%
$1.14
Discover more tools and features to empower your trading
Explore Features

Quotes and other market data may be delayed by 15 minutes or more. Financial data is provided by financial exchanges and other content providers and may be delayed as specified by financial exchanges or other data providers. AfterPullback does not verify any data and disclaims any obligation to do so. The information contained on this website is not intended as, and shall not be understood as, financial advice. The website does not operated by attorney, accountant or financial advisor and the information contained on this website is not a substitute for financial advice from a professional who is aware of the facts and circumstances of your individual situation. Nothing available on or through this website should be understood as a recommendation that you should not consult with a financial professional to address your particular information.